Show
Sort by
-
- Journal Article
- A1
- open access
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy
-
- Journal Article
- A1
- open access
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer : a multicenter, single-arm phase 2a study
-
- Journal Article
- A1
- open access
Cytokine-armed oncolytic herpes simplex viruses : a game-changer in cancer immunotherapy?
-
- Journal Article
- A1
- open access
Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer
-
- Journal Article
- A1
- open access
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
-
- Journal Article
- A1
- open access
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma : a phase II clinical trial
-
- Journal Article
- A1
- open access
Local anesthetics elicit immune-dependent anticancer effects
-
Cabozantinib plus atezolizumab in advanced head and neck cancer previously treated with platinum-containing chemotherapy : results from cohort 17 of the COSMIC-021 study
(2022) JOURNAL FOR IMMUNOTHERAPY OF CANCER. In Journal for Immunotherapy of Cancer 10(Supplement 2). p.A597-A597 -
- Conference Paper
- C3
- open access
A phase 1B multi-tumor cohort study of cabozantinib plus atezolizumab in advanced solid tumors : results of the triple-negative breast cancer, ovarian cancer, and endometrial cancer cohorts
(2021) JOURNAL FOR IMMUNOTHERAPY OF CANCER. In Journal for Immunotherapy of Cancer 9(Supplement 2). p.A562-A562 -
- Journal Article
- A1
- open access
Targeting immunogenic cancer cell death by photodynamic therapy : past, present and future